Cargando...
Ustekinumab for the treatment of Crohn’s disease: can it find its niche?
Crohn’s disease is an immune-mediated disease that results in panenteric chronic inflammation in genetically predisposed individuals exposed to an appropriate environment. The past two decades have witnessed the emergence of an important class of drugs known as anti-tumour necrosis factor (TNF) agen...
Gardado en:
| Publicado en: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699281/ https://ncbi.nlm.nih.gov/pubmed/26770265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X15618130 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|